Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Pediatric Reviews
  4. Volume 21, Issue 2
  5. Article
Volume 21, Issue 2
  • ISSN: 1573-3963
  • E-ISSN: 1875-6336

Abstract

Purpose

The survival of paediatric oncology patients has improved substantially in the past decades due to advances in the field of oncology. Modern cancer treatments often come with life-threatening complications, of which infection is one of the most common causes in this patient population. This study aims to investigate the prevalence and outcomes of common infections in haemato-oncology patients during their stay in paediatric intensive care unit (PICU) and to identify any factors associated with these infections.

Methods

A retrospective observational study was conducted on all children with a haemato-oncology diagnosis or who underwent haematopoietic stem cell transplantation (HSCT) and who were admitted to the Hong Kong Children’s Hospital PICU over a one-year period. Infection characteristics and patient outcomes were evaluated and compared between different sub-groups. Univariable and multi-variable analyses were employed to identify risk factors associated with the development of active infection.

Results

Forty-five (36.3%) of 124 critically ill haemato-oncology admissions to PICU were associated with infections, of which 31 (25%) admissions involved bacterial infections, 26 (20.9%) involved viral infections and 6 (4.8%) involved fungal infections. Bloodstream infection was the most common type of infection. More than half (61.3%) of the bacterial infections were due to an antibiotic-resistant strain. After adjusting for confounding variables, post-HSCT status and neutropenia were significantly associated with active infections.

Conclusion

Infections in critically-ill haemato-oncological patients are associated with post haematopoietic stem cell transplant status and neutropenia. Further study is warranted to review effective strategies that may mitigate the likelihood of infection in this patient population.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpr/10.2174/0115733963264717231208114248
2024-01-24
2024-12-24

  • From This Site

    /content/journals/cpr/10.2174/0115733963264717231208114248
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. AljabariS. BalchA. LarsenG.Y. FluchelM. WorkmanJ.K. Severe sepsis-associated morbidity and mortality among critically ill children with cancer.J. Pediatr. Inten. Care20198312212910.1055/s‑0038‑167665831404226
     [Google Scholar]
  2. JenaS. HasanS. PanigrahiR. DasP. MishraN. SaeedS. Chemotherapy-associated oral complications in a south Indian population: A cross-sectional study.J. Med. Life202215447047810.25122/jml‑2021‑034235646189
     [Google Scholar]
  3. BaileyL.C. ReillyA.F. RheingoldS.R. Infections in pediatric patients with hematologic malignancies.Semin. Hematol.200946331332410.1053/j.seminhematol.2009.03.01019549582
     [Google Scholar]
  4. Steliarova-FoucherE. StillerC. LacourB. KaatschP. International classification of childhood cancer, third edition.Cancer200510371457146710.1002/cncr.2091015712273
     [Google Scholar]
  5. StraneyL. ClementsA. ParslowR.C. PearsonG. ShannF. AlexanderJ. SlaterA. Paediatric index of mortality 3: An updated model for predicting mortality in pediatric intensive care.Pediatr. Crit. Care Med.201314767368110.1097/PCC.0b013e31829760cf23863821
     [Google Scholar]
  6. European Society of Paediatric and Neonatal Intensive CarePaediatric Logistic Organ Dysfunction 2 Score Calculator.2021Available from:https://www.espnic.eu/calcolatori/Paediatric%20Logistic%20Organ%20Dysfunction%202%20Score%20Calculator%20_%20Professional%20Resources%20_%20Education%20-%20European%20Society%20of%20Paediatric%20Neonatal%20Intensive%20Care%20-%20ESPNIC_files.htm
  7. University of Leeds and LeicesterPICANet admission dataset definitions manual.2020Available from:https://www.picanet.org.uk/wp-content/uploads/sites/25/2020/11/PICANet-Web-Admission-Dataset-Manual-v5.4_-Nov-2020.pdf
  8. National Health Service DigitalOrgan system supported.2021Available from:https://www.datadictionary.nhs.uk/data_elements/organ_system_supported.html
  9. JonesG.A.L. RamnarayanP. RamanS. InwaldD. GrocottM.P.W. EatonS. RayS. GriksaitisM.J. PappachanJ. WileyD. MounceyP.R. WulffJ. HarrisonD.A. RowanK.M. PetersM.J. Protocol for a randomised pilot multiple centre trial of conservative versus liberal oxygenation targets in critically ill children (Oxy-PICU).BMJ Open2017712e01925310.1136/bmjopen‑2017‑01925329247112
     [Google Scholar]
  10. GoldsteinB. GiroirB. RandolphA. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics.Pediatr. Crit. Care Med.2005612810.1097/01.PCC.0000149131.72248.E615636651
     [Google Scholar]
  11. MeertK.L. BanksR. HolubkovR. PollackM.M. Morbidity and mortality in critically Ill children. II. A qualitative patient-level analysis of pathophysiologies and potential therapeutic solutions.Crit. Care Med.202048679980710.1097/CCM.000000000000433232301845
     [Google Scholar]
  12. PollackM.M. HolubkovR. FunaiT. ClarkA. BergerJ.T. MeertK. NewthC.J.L. ShanleyT. MolerF. CarcilloJ. BergR.A. DaltonH. WesselD.L. HarrisonR.E. DoctorA. DeanJ.M. JenkinsT.L. Pediatric intensive care outcomes: Development of new morbidities during pediatric critical care.Pediatr. Crit. Care Med.201415982182710.1097/PCC.000000000000025025226501
     [Google Scholar]
  13. PollackM.M. HolubkovR. GlassP. DeanJ.M. MeertK.L. ZimmermanJ. AnandK.J.S. CarcilloJ. NewthC.J.L. HarrisonR. WillsonD.F. NicholsonC. Functional status scale: New pediatric outcome measure.Pediatrics20091241e18e2810.1542/peds.2008‑198719564265
     [Google Scholar]
  14. PollackMM BanksR HolubkovR MeertKL Long-term outcome of picu patients discharged with new, functional status morbidity.Pediatr. Crit. Care Med.20202212739
     [Google Scholar]
  15. PollackM.M. BanksR. HolubkovR. MeertK.L. Morbidity and mortality in critically Ill children. I. Pathophysiologies and potential therapeutic solutions.Crit. Care Med.202048679079810.1097/CCM.000000000000433132301842
     [Google Scholar]
  16. LeungK.K.Y. RayS. ChanG.C.F. HonK.L. Functional outcomes at PICU discharge in hemato-oncology children at a tertiary oncology center in Hong Kong.Int. J. Clin. Oncol.202227121904191510.1007/s10147‑022‑02244‑336149516
     [Google Scholar]
  17. CalandraT. CohenJ. The international sepsis forum consensus conference on definitions of infection in the intensive care unit.Crit. Care Med.20053371538154810.1097/01.CCM.0000168253.91200.8316003060
     [Google Scholar]
  18. DorofaeffT. Mohseni-BodH. CoxP.N. Infections in the PICU.Textbook of Clinical Pediatrics.Berlin, HeidelbergSpringer20122537256310.1007/978‑3‑642‑02202‑9_268
     [Google Scholar]
  19. Peter DonnellyJ. ChenS.C. KauffmanC.A. SteinbachW.J. BaddleyJ.W. VerweijP.E. Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium.Clin. Infect. Dis.20207161367137610.1093/cid/ciz100831802125
     [Google Scholar]
  20. VincentJ.L. RelloJ. MarshallJ. SilvaE. AnzuetoA. MartinC.D. MorenoR. LipmanJ. GomersallC. SakrY. ReinhartK. International study of the prevalence and outcomes of infection in intensive care units.JAMA2009302212323232910.1001/jama.2009.175419952319
     [Google Scholar]
  21. McArdleA.J. TurkovaA. CunningtonA.J. When do co-infections matter?Curr. Opin. Infect. Dis.201831320921510.1097/QCO.000000000000044729698255
     [Google Scholar]
  22. GrohskopfL.A. Sinkowitz-CochranR.L. GarrettD.O. SohnA.H. LevineG.L. SiegelJ.D. StoverB.H. JarvisW.R. A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States.J. Pediatr.2002140443243810.1067/mpd.2002.12249912006957
     [Google Scholar]
  23. Ford-JonesE.L. MindorffC.M. LangleyJ.M. AllenU. NàvàsL. PatrickM.L. MilnerR. GoldR. Epidemiologic study of 4684 hospital-acquired infections in pediatric patients.Pediatr. Infect. Dis. J.198981066867510.1097/00006454‑198910000‑000022812911
     [Google Scholar]
  24. RaymondJ. AujardY. Nosocomial infections in pediatric patients: A European, multicenter prospective study.Infect. Control Hosp. Epidemiol.200021426026310.1086/50175510782588
     [Google Scholar]
  25. de León-RosalesS.P. Molinar-RamosF. Domínguez-CheritG. Rangel-FraustoS.M. Vázquez-RamosV.G. Prevalence of infections in intensive care units in Mexico: A multicenter study.Crit. Care Med.20002851316132110.1097/00003246‑200005000‑0001010834672
     [Google Scholar]
  26. BarsantiM.C. WoeltjeK.F. Infection prevention in the intensive care unit.Infect. Dis. Clin. North Am.200923370372510.1016/j.idc.2009.04.01219665091
     [Google Scholar]
  27. AlexanderS. NiederM. ZerrD.M. FisherB.T. DvorakC.C. SungL. Prevention of bacterial infection in pediatric oncology: What do we know, what can we learn?Pediatr. Blood Cancer2012591162010.1002/pbc.2341622102612
     [Google Scholar]
  28. University of Wisconsin Hospitals and Clinics AuthorityGranulocyte colony stimulating factor - Adult/Pediatric - Inpatient/ambulatory clinical practice guideline.2015Available from: https:// www.uwhealth.org/cckm/cpg/medications/Granulocyte-Colony-Stimulating-Factor---Pediatric.Adult---Inpatient.Ambulatory-15.09.18---new-links.pdf
  29. ClarkO.A.C. LymanG.H. CastroA.A. ClarkL.G.O. DjulbegovicB. Colony-stimulating factors for chemotherapy-induced febrile neutropenia: A meta-analysis of randomized controlled trials.J. Clin. Oncol.200523184198421410.1200/JCO.2005.05.64515961767
     [Google Scholar]
  30. MillerS.E. MaragakisL.L. Central line-associated bloodstream infection prevention.Curr. Opin. Infect. Dis.201225441242210.1097/QCO.0b013e328355e4da22766647
     [Google Scholar]
  31. RenkH. SarmisakE. SpottC. KumpfM. HofbeckM. HölzlF. Antibiotic stewardship in the PICU: Impact of ward rounds led by paediatric infectious diseases specialists on antibiotic consumption.Sci. Rep.2020101882610.1038/s41598‑020‑65671‑032483370
     [Google Scholar]
  32. O’ConnellN.H. HumphreysH. Intensive care unit design and environmental factors in the acquisition of infection.J. Hosp. Infect.200045425526210.1053/jhin.2000.076810981659
     [Google Scholar]
  33. KollefM.H. MicekS.T. Strategies to prevent antimicrobial resistance in the intensive care unit.Crit. Care Med.20053381845185310.1097/01.CCM.0000171849.04952.7916096464
     [Google Scholar]
  34. RimawiR.H. MazerM.A. SirajD.S. GoochM. CookP.P. Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome.Crit. Care Med.20134192099210710.1097/CCM.0b013e31828e986323873275
     [Google Scholar]
  35. LehrnbecherT. RobinsonP. FisherB. AlexanderS. AmmannR.A. BeaucheminM. CarlesseF. GrollA.H. HaeuslerG.M. SantolayaM. SteinbachW.J. CastagnolaE. DavisB.L. DupuisL.L. GaurA.H. TissingW.J.E. ZaoutisT. PhillipsR. SungL. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 Update.J. Clin. Oncol.201735182082209410.1200/JCO.2016.71.701728459614
     [Google Scholar]
  36. WingardJ.R. Overview of infections following hematoietic cell transplantation.UpToDate. PostT.W. Waltham, MA2020
     [Google Scholar]
  37. ChoS.Y. LeeH.J. LeeD.G. Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea.Korean J. Intern. Med. (Korean. Assoc. Intern. Med.)201833225627610.3904/kjim.2018.03629506345
     [Google Scholar]
  38. BallettoE. MikulskaM. Bacterial infections in hematopoietic stem cell transplantation recipients.Mediterr. J. Hematol. Infect. Dis.201571e201504510.4084/mjhid.2015.04526185610
     [Google Scholar]
  39. TomblynM. ChillerT. EinseleH. GressR. SepkowitzK. StorekJ. WingardJ.R. YoungJ.A.H. BoeckhM.A. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: A global perspective.Biol. Blood Marrow Transplant.200915101143123810.1016/j.bbmt.2009.06.01919747629
     [Google Scholar]
  40. BlotN. SchneiderP. YoungP. JanvresseC. DehesdinD. TronP. VannierJ.P. Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant.Bone Marrow Transplant.200026890390510.1038/sj.bmt.170259111081393
     [Google Scholar]
  41. BlackstockJ.L. ParikhS.H. TalbertJ.G. Herpes simplex virus in the pediatric bone marrow and stem cell transplantation patient.Biol. Blood Marrow Transplant.2005112979810.1016/j.bbmt.2004.12.288
     [Google Scholar]
  42. Committee on Infectious DiseasesRed Book 2018: Report of the Committee on Infectious Diseases.American Academy of Pediatrics2018
     [Google Scholar]
  43. EmeryV. ZuckermanM. JacksonG. AitkenC. OsmanH. PagliucaA. PotterM. PeggsK. ClarkA. Management of cytomegalovirus infection in haemopoietic stem cell transplantation.Br. J. Haematol.20131621253910.1111/bjh.1236323647436
     [Google Scholar]
  44. ChoS.Y. LeeD.G. KimH.J. Cytomegalovirus infections after hematopoietic stem cell transplantation: Current status and future immunotherapy.Int. J. Mol. Sci.20192011266610.3390/ijms2011266631151230
     [Google Scholar]
  45. BoeckhM. LjungmanP. How we treat cytomegalovirus in hematopoietic cell transplant recipients.Blood2009113235711571910.1182/blood‑2008‑10‑14356019299333
     [Google Scholar]
  46. StyczynskiJ. van der VeldenW. FoxC.P. EngelhardD. de la CamaraR. CordonnierC. LjungmanP. Management of epstein-barr virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth european conference on infections in leukemia (ECIL-6) guidelines.Haematologica2016101780381110.3324/haematol.2016.14442827365460
     [Google Scholar]
  47. LinR. LiuQ. Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation.J. Hematol. Oncol.2013619410.1186/1756‑8722‑6‑9424341630
     [Google Scholar]
  48. CollacoJ.M. GowerW.A. MogayzelP.J.Jr Pulmonary dysfunction in pediatric hematopoietic stem cell transplant patients: Overview, diagnostic considerations, and infectious complications.Pediatr. Blood Cancer200749211712610.1002/pbc.2106117029246
     [Google Scholar]
  49. KampmannB. CubittD. WallsT. NaikP. DepalaM. SamarasingheS. RobsonD. HassanA. RaoK. GasparH. DaviesG. JonesA. CaleC. GilmourK. RealM. FooM. Bennett-ReesN. HewittA. AmroliaP. VeysP. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation.Br. J. Haematol.2005130459560310.1111/j.1365‑2141.2005.05649.x16098075
     [Google Scholar]
  50. ChakrabartiS. CollinghamK.E. FeganC.D. PillayD. MilliganD.W. Adenovirus infections following haematopoietic cell transplantation: Is there a role for adoptive immunotherapy?Bone Marrow Transplant.200026330530710.1038/sj.bmt.170250810967570
     [Google Scholar]
  51. TragiannidisA. DokosC. LehrnbecherT. GrollA.H. Antifungal chemoprophylaxis in children and adolescents with haematological malignancies and following allogeneic haematopoietic stem cell transplantation: Review of the literature and options for clinical practice.Drugs201272568570410.2165/11599810‑000000000‑0000022413762
     [Google Scholar]
  52. AlfaroG.M.M. GansH.A. Prevention of infections in the hematopoietic stem cell transplant recipient.Pediatric Transplant and Oncology Infectious Diseases.Philadelphia, PAElsevier20214653
     [Google Scholar]
  53. MaertensJ. CesaroS. MaschmeyerG. EinseleH. DonnellyJ.P. AlanioA. HauserP.M. LagrouK. MelchersW.J.G. Helweg-LarsenJ. MatosO. BretagneS. CordonnierC. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.J. Antimicrob. Chemother.20167192397240410.1093/jac/dkw15727550992
     [Google Scholar]
  54. BurtonC. HanischB. Pneumocystis pneumonia.Pediatric Transplant and Oncology Infectious Diseases.Philadelphia, PAElsevier2020241246.e3
     [Google Scholar]
/content/journals/cpr/10.2174/0115733963264717231208114248
Loading
Prevalence and Outcomes of Infections in Critically-ill Paediatric Oncology Patients: A Retrospective Observation Study
Curr Pediatr Rev 21, 174 (2025); https://doi.org/10.2174/0115733963264717231208114248
/content/journals/cpr/10.2174/0115733963264717231208114248
/content/journals/cpr/10.2174/0115733963264717231208114248
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): Critical care; critical illness; haematology; infection; intensive care; oncology; paediatrics; stem cell transplantation

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test